Last update 23 Jan 2025

Recombinant human insulin(Nutrinia Ltd.)

Overview

Basic Info

Drug Type
Hormone
Synonyms
Target
INSR
Mechanism
INSR agonists(Insulin receptor agonists)
Therapeutic Areas
Digestive System DisordersEndocrinology and Metabolic DiseaseOther Diseases
Active Indication-
Inactive Indication
Diabetes Mellitus, Type 2Short Bowel Syndrome
Originator Organization
Nutrinia Ltd.Nutrinia Ltd.
Active Organization-
Inactive Organization
Nutrinia Ltd.Nutrinia Ltd.Hefei Haimaitongheng Biotechnology Co., Ltd.Elgan Pharma Ltd.Elgan Pharma Ltd.Startup
+ [2]
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Recombinant human insulin(Nutrinia Ltd.)
NCT02865122
/ TerminatedPhase 2/3
A Multi-Center, Randomized, Double-Blind, Three-Arm, Parallel-Group Trial to Assess the Efficacy and Safety of NTRA-9620 in Infants With Short Bowel Syndrome (SBS) Following Surgical Resection
100 Clinical Results associated with Recombinant human insulin(Nutrinia Ltd.)
Login to view more data
100 Translational Medicine associated with Recombinant human insulin(Nutrinia Ltd.)
Login to view more data
100 Patents (Medical) associated with Recombinant human insulin(Nutrinia Ltd.)
Login to view more data
100 Deals associated with Recombinant human insulin(Nutrinia Ltd.)
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
A10AF01A10AD01A10AC01A10AB01A10AE01
-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2Phase 3
CN
Israel Oramd Co Ltd
13 Oct 2020
Diabetes Mellitus, Type 2Phase 3
CN
Swiss Caps AG
13 Oct 2020
Diabetes Mellitus, Type 2Phase 3
CN
Hefei Haimaitongheng Biotechnology Co., Ltd.
13 Oct 2020
Short Bowel SyndromePhase 3
US
Elgan Pharma Ltd.Elgan Pharma Ltd.Startup
20 Mar 2017
Short Bowel SyndromePhase 3
US
Nutrinia Ltd.Nutrinia Ltd.
20 Mar 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT02865122 (GIFT, CTgov)
Phase 2/3
Short Bowel Syndrome
2
(NTRA-9620-A)
yohlbxiymy(ekopwwrbol) = nxwwpruhot qvxcxdslla (cvgkmiuglx, lmlnpwkskp - watnpfptbw)
View more
-
12 Oct 2021
(NTRA-9620-B)
yohlbxiymy(ekopwwrbol) = xvlrvxqxpd qvxcxdslla (cvgkmiuglx, ustcifxhqn - dtlpqzxfjg)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free